a16z and Insitro Experts: Biological Measurement Must Improve Before Blind Scaling
anshulkundaje · x · 2026-08-05
In a discussion involving a16z and Daphne Koller's Insitro, industry voices point out that biological measurement capabilities need to be improved before blindly applying scale-maximizing strategies. This highlights the fundamental data acquisition bottlenecks faced by AI in specific verticals.
Related event: insitro CEO Daphne Koller: AI Drug Discovery Has No Magic Wand Yet(7 posts)→
More from AGI Musings
- Rumor: SSI Solved Continual Learning, But Alignment Becomes Harder — teortaxesTex · 2026-08-05
- Experts from Odyssey and 1x to Discuss World Models in Embodied AI — Exp_Mark · 2026-08-05
- Top Researchers Launch 'Pax Machina' to Debate Institutions for Powerful AI — edelwax · 2026-08-05
- Settled Science vs. Breaking News: Why Core Psychology Findings Hold Up — Astral Codex Ten · 2026-08-05
- Restructuring Work in the AI Era: Become the Designer of Your Own Job — every · 2026-08-05
- Musk: AI and Robotics Will Trigger Unprecedented Global Bandwidth Demand — XFreeze · 2026-08-05